Longeveron Inc. Reconstitutes Audit Committee, Restores Nasdaq Compliance

What Happened Longeveron Inc. (LGVN) announced that it temporarily fell out of compliance with Nasdaq Listing Rule 5605(c)(2)(A) in March 2026, which requires an audit committee of at least three independent directors with at least one audit committee financial expert. After electing three new directors at its July annual meeting, the Board on July 24, 2026 approved reconstituting the Audit Committee to include Dr. Deborah Ascheim, Ms. Leah Rush Cann, Dr. George Paletta and Ms. Ursula Ungaro. Each member is independent, and Ms. Leah Rush Cann qualifies as the required audit committee financial expert under Item 407(d)(5)(ii) of Regulation S‑K.

Key Details

• The company was temporarily non‑compliant with Nasdaq Listing Rule 5605(c)(2)(A) in March 2026.
• Board reconstitution approved on July 24, 2026 following the July annual meeting.
• Audit Committee members: Dr. Deborah Ascheim, Ms. Leah Rush Cann (audit committee financial expert), Dr. George Paletta, Ms. Ursula Ungaro.
• Committee now meets Nasdaq independence and financial‑expert requirements.

Why It Matters Restoring a fully independent audit committee with a designated financial expert addresses the Nasdaq rule violation and reduces regulatory and listing risk. For investors, a properly constituted audit committee strengthens oversight of financial reporting, audits, and quarterly and annual results—supporting confidence in the integrity of Longeveron’s financial disclosures. No other operational or financial changes were reported in the filing.